Harrow

1. IHEEZO topline4Q 2026IHEEZO topline, 4Q 2026, material
2. NATACYN topline4Q 2026NATACYN topline, 4Q 2026, material
3. G-MELT corporate updateearly 4Q 2026G-MELT corporate update, early 4Q 2026, routine
4. Harrow corporate updateNov 2026Harrow corporate update, Nov 2026, material
5. TRIESENCE Ph3 toplineEarly 2027TRIESENCE Ph3 topline, Early 2027, material
6. G-MELT NDA filing1H 2027G-MELT NDA filing, 1H 2027, notable
7. OPUVIZ commercial launchJan 2027OPUVIZ commercial launch, Jan 2027, routine
8. BYQLOVI corporate updateMar 4, 2027BYQLOVI corporate update, Mar 4, 2027, routine
9. Harrow notes corporate updateMar 15, 2027Harrow notes corporate update, Mar 15, 2027, routine
10. Novaliq non-compete divestiture clock corporateOct 2027Novaliq non-compete divestiture clock corporate, Oct 2027, routine
11. G-MELT FDA approval1H 2028G-MELT FDA approval, 1H 2028, material
12. TRIESENCE corporate updateMar 31, 2028TRIESENCE corporate update, Mar 31, 2028, routine
13. TYRVAYA corporate updateApr–May 2028TYRVAYA corporate update, Apr–May 2028, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.